Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
ARAY · against 557 other Healthcare companies listed in US-listed
Ranked #210 of 558 · scores higher than 61% of peers
Bars: peers in each 10-point band of the profitability score33 peers with a profitability score of 40–49, including ARAY · Click a bar to see the companies
A mix: stronger return on invested capital, but weaker operating margin and return on assets than most Healthcare peers.
| Metric | ARAY | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 517 reported | 10.7% | -7.0% | 77% | 33% | |
| Operating marginHigher is better · 479 reported | -2.6% | -2.4% | 50% | 33% | |
| Return on assetsHigher is better · 582 reported | -1.4% | -7.8% | 59% | 33% | |
| Return on equityHigher is better · 531 reported | -80.1% | -19.7% | 17% | Context only | |
| Gross marginHigher is better · 601 reported | 27.7% | 43.9% | 42% | Context only |
| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 595M USD | 99 | 97 | |
| 1 | 433M USD | 99 | 81 | |
| 1 | 17.9B USD | 99 | 76 | |
| 1 | 52.9B USD | 99 | 57 | |
| 1 | 578M USD | 99 | 73 | |
| 207 | 3.1B USD | 42 | 53 | |
| 207 | 1.1B USD | 42 | 43 | |
| 207 | 1.5B USD | 42 | 59 | |
| 210 | 1.2B USD | 41 | 42 | |
| 210 | 17M USD | 41 | 16 | |
| 210 | 10.8B USD | 41 | 41 | |
| 210 | 15.7B USD | 41 | 33 | |
| 210 | 4.0B USD | 41 | 46 | |
| 210 | 10.8B USD | 41 | 35 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score